个人认知刺激治疗对痴呆患者认知功能和抑郁情绪的影响:系统性审查和元分析
概括
个性化认知刺激疗法 (ICST) 显著改善了痴呆患者的认知功能,并减少了痴呆患者的抑郁症. 需要进一步的研究来证实这些发现,并探索潜在的机制.
科学领域:
- 老年学是指老年学的学科.
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 痴呆症是一种进展性神经退行性疾病,其特征是认知能力下降.
- 认知刺激疗法 (CST) 是一种非药物干预,旨在改善痴呆症患者的认知功能.
- 个性化认知刺激疗法 (ICST) 为CST提供了个性化的治疗方法.
研究的目的:
- 评估个性化认知刺激疗法 (ICST) 在改善痴呆症患者的认知功能和减少抑郁症方面的疗效.
- 通过元分析,综合现有干预研究的证据.
主要方法:
- 对痴呆症患者的ICST进行干预研究,对中国和英语数据库进行了系统的搜索.
- 使用Review Manager 5.3软件进行了元分析,以分析收集的数据.
主要成果:
- 通过迷你精神状态检查 (MMSE) 测量,ICST显著改善了认知功能 (MD: 1.65;95% CI: 0.06-3.24).
- 在阿尔茨海默氏病评估尺度 (ADAS-Cog) 的认知子尺度上没有观察到显著影响.
- ICST导致抑郁症显著减少 (MD:-1.18;95% CI:-2.14至-0.22),但没有显著影响生活质量,神经精神症状或日常生活活动.
结论:
- ICST是一种有效的干预措施,可以增强痴呆症患者的认知能力并减轻痴呆症患者的抑郁症状.
- 需要进一步的研究来验证这些发现,并阐明ICST影响背后的潜在机制.
更多相关视频
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
632
08:18A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
Published on: December 26, 2015
17.5K
相关概念视频
01:25Cognitive Therapy
466
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
466
01:30Cognitive Development During Adulthood
312
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
312
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
214
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
214
01:22Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
01:30Electroconvulsive Therapy
205
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
205